Home/Filings/8-K/0001493152-26-000248
8-K//Current report

Ingevity Corp 8-K

Accession 0001493152-26-000248

$NGVTCIK 0001653477operating

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 6:39 AM ET

Size

2.7 MB

Accession

0001493152-26-000248

Research Summary

AI-generated summary of this filing

Updated

Ingevity Corp Completes Asset Sale of Industrial Specialties and Refinery

What Happened

  • Ingevity Corporation announced it completed the disposition required by an Asset Purchase Agreement: on January 1, 2026 Buyer Mainstream Pine Products, LLC purchased substantially all assets and assumed certain rights and liabilities related to (a) Ingevity’s industrial specialties product line (with specified exceptions) and (b) Ingevity’s North Charleston, South Carolina crude tall oil refinery and related operations.
  • Concurrently on January 1, 2026 the parties executed a First Amendment to the Asset Purchase Agreement that narrowed the scope of assets being transferred by excluding non‑lignin dispersant products sold to existing customers for agricultural chemical applications. The original Purchase Agreement was dated September 3, 2025 and remains in effect except as amended.

Key Details

  • Closing and Amendment date: January 1, 2026.
  • Buyer: Mainstream Pine Products, LLC (per the Asset Purchase Agreement filed Sept 3, 2025).
  • Assets sold: substantially all assets related to Ingevity’s industrial specialties product line (subject to enumerated exceptions) and the North Charleston, SC crude tall oil refinery and its operations.
  • Amendment effect: excludes non‑lignin dispersant products sold to existing agricultural chemical customers from the transferred assets.
  • Press release announcing the transaction was filed as Exhibit 99.1 on January 5, 2026.

Why It Matters

  • This filing reports a completed, material disposition of key operating assets—changes that can affect Ingevity’s revenue mix, operations and asset base.
  • The amendment narrows what was sold by carving out certain agricultural dispersant products, which may preserve related customer relationships or revenue streams for Ingevity.
  • The 8‑K does not disclose purchase price or detailed financial impacts; investors should review the press release and future filings for financial effects and management commentary.